Since increased p38MAPK phosphorylation has been described in the CNS upon EAE induction [25], and its pharmacological blockade has shown to inhibit the differentiation of CD4 T cells into Th17 cells, both in MS and the animal model [26, 27], our results appear counterintuitive. Here, CD4 is linked to myeloid sarcoma.